The legalization of medical marijuana last year in Pennsylvania ended years of lobbying but also started new debates as businesses applied for grow permits and dispensary permits.
The dispensary permits determine the locations where patients with doctor’s prescriptions can purchase the cannabis products prescribed for the 17 different ailments the law identifies as being able to be treated. Among them are epilepsy, cancer, autism, glaucoma, HIV, Parkinson’s, multiple sclerosis and post-traumatic stress disorder.
The legalization of medical marijuana is spawning a lucrative, new pharmaceutical industry in Pennsylvania, with positive ramifications for communities – and controversy about how and where permits have been awarded.
READ THE FULL STORY BELOW
